{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT04134728: Phase 3 Interventional Completed Arthritis, Rheumatoid
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03811028: Phase 1/Phase 2 Interventional Completed Sanfilippo Syndrome Type A (MPS IIIA)
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03921541: Phase 3 Interventional Completed Arginase I Deficiency
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04665856: Phase 3 Interventional Active, not recruiting Small Cell Lung Carcinoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02472145: Phase 2/Phase 3 Interventional Completed Leukemia, Myeloid, Acute
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02605525: Phase 2 Interventional Withdrawn Immunoglobulin A Nephropathy
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02859961: Phase 2/Phase 3 Interventional Completed HIV
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03631706: Phase 3 Interventional Completed Non-small Cell Lung Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02754076: Phase 1/Phase 2 Interventional Completed MPS III B
(2016)
Source URL:
Class:
PROTEIN